10x Genomics guides higher Q4 & FY revenue than consensus (TXG:NASDAQ)

Last updated: January 13, 2025 8:52 am

By MT HANNACH

Add a Comment

0 Min Read

Disclosure: This website may contain affiliate links, which means I may earn a commission if you click on the link and make a purchase. I only recommend products or services that I personally use and believe will add value to my readers. Your support is appreciated!

From the 3rd to the 4th symbol of the quarter. Transformed wooden cubes and changed words — Dzmitri Dzemidovitch

10x Genomics (NASDAQ:XXL) wait Fourth quarter revenue of approximately $165 million, representing a 9% quarter-on-quarter growth and a 10% year-over-year decrease; the figure remains higher than consensus estimates of $153.51 million.
The highest annual growth is estimated to come from the services segment, while instruments